Abstract:Objective: Since the first report on 1992 by Rukstalis and Chodak, laparoscopic retroperitoneal lymph node dissection (L-RLND) remains the most accurate method of assessing lymph node status in clinically stage I and II nonseminomatous germ cell tumors (NSGCT).1–4 Most of the RLND were performed trans peritoneal cavity. LeBlanc et al reported the L-RLND via retroperitoneal approach, which could avoid the interference to abdominal organs and get better exposure.4–6 We made some modifications to improve this technique and investigated the surgical techniques and clinical feasibility of the extraperitoneal L-RLND (EL-RLND). Materials and Methods: Three patients with primary testicular NSGCT on the right side received EL-RLND at 16, 28, and 31 days after orchiectomy. An incision of approximately 15 mm was made 2 cm medial to the right anterior superior iliac spine. The fascia of the external oblique muscles was cut. The internal oblique and transverse muscles were then bluntly divided. The retroperitoneal space was developed by inflating a preperitoneal balloon device with 900 mL of air. After removing the balloon device, a 10-mm laparoscopic trocar was placed at the existing surgical wound, which served as the camera port. Under laparoscopic observation, additional trocars were placed along the lateral border of the ipsilateral rectus abdominis or along the middle axillary line. The aorta, inferior vena cava, and surrounding adipose and lymphoid tissue were exposed. Dissection and ligation of testicular blood vessels and vas deferens were performed. Then, all para-aortic tissue lateral to the aorta and preaortic tissue cephalad to the inferior mesenteric artery was removed. The boundaries of dissection included renal vein (proximal), bifurcation of common iliac vessel (distal), ureter (lateral), and para-abdominal aorta/inferior vena cava area (medial). All tissue specimens were placed in an organ entrapment sack and removed. Results: The EL-RLND was performed in all the three patients. The average operating time was 180 min, the average intraoperative blood loss was 350 mL, the postoperative intestinal function recovery time was 2 days, and the average hospitalization time was 7 days. Follow-up revealed no evidence of recurrence or distant metastasis. Conclusions: EL-RLND that can be further applied is an operation for nonseminomatous testis cancer with minimal invasiveness, quick recovery. Because it is a difficult and complicated procedure performed near the large vessels, EL-RLND needs more experience on laparoscopic techniques to minimize complications. No competing financial interests exist. Runtime of video: 9 mins 9 secs

Lymph Node Dissection in Testicular Cancer: The State of the Art and Future Perspectives

[Transperitoneal Laparoscopic Modified Lymph Node Dissection for Clinical Stage I Nonseminomatous Germ Cell Testicular Carcinoma].

Lymph Node Dissection in Upper Tract Urothelial Carcinoma: Current Status and Future Perspectives

Testicular cancer with small metastatic burden: optimal approach in 2024

Primary retroperitoneal lymph node dissection in stage II testicular seminoma: a systematic review

[Primary retroperitoneal lymph node dissection in testicular germ cell cancer in clinical stage IIA/B-renaissance of an established treatment?]

laparoscopic retropenitoneal lymph node dissection in the treatment of testicular tumor

Primary retroperitoneal lymph node dissection for clinical stage II seminoma: A systematic review and meta-analysis of safety and oncological effectiveness

Retroperitoneal Lymph Node Dissection in Colorectal Cancer with Lymph Node Metastasis: A Systematic Review

Outcomes after primary retroperitoneal lymph node dissection in men with stage 2 non-seminomatous germ cell tumour: A multicenter retrospective cohort study.

Single-stage retrocrural and retroperitoneal lymph node dissection for metastatic germ cell tumor: The University of Southern California experience.

The role and controversy of pelvic lymph node dissection in prostate cancer treatment: a focused review

Metastasis-directed therapy in testicular cancer

Mini-review: Evaluation and Management of Retroperitoneal Masses in Patients with Testicular Cancer

Extraperitoneal Laparoscopic Retroperitoneal Lymph Node Dissection for Early-Stage Testicular Nonseminomatous Germ Cell Tumors: Initial Experience

Sentinel lymph node biopsy in endometrial cancer: When, how and in which patients

Lymph node density as a prognostic marker of relapse in patients who underwent primary retroperitoneal lymph node dissection

The role of lateral pelvic lymph node dissection in advanced rectal cancer: a review of current evidence and outcomes

Advancements in Diagnosis and Multimodal Treatment Strategies for Retroperitoneal Tumors

Primary Retroperitoneal Lymph Node Dissection for Stage II Seminoma: Is Surgery the New Path Forward?

Extraperitoneal Laparoscopic Retroperitoneal Lymph Node Dissection